Jiri Eitler
Technische Universität Dresden
H-index: 5
Europe-Germany
Top articles of Jiri Eitler
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation
Journal for Immunotherapy of Cancer
2024
Jiri Eitler
H-Index: 4
Michael Bachmann
H-Index: 9
442-Q CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation
2023/11/1
Jiri Eitler
H-Index: 4
Johannes Huppa
H-Index: 20
Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer
Frontiers in Immunology
2023/10/11
Jiri Eitler
H-Index: 4
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
Frontiers in Immunology
2023/9/25
Live-cell imaging for analysis of the NK cell immunological synapse
2023/1/1
Jiri Eitler
H-Index: 4
216 Dual targeting of CAR-NK cells to PD-L1 and ErbB2 facilitates specific elimination of cancer cells of solid tumor origin and overcomes immune escape by antigen loss
2022/11/1
Jiri Eitler
H-Index: 4
KTeXpand–a novel microfluidic device for advanced cell based cross matching
2022/9/2
Daniel Schneider
H-Index: 14
Jiri Eitler
H-Index: 4
Correction: Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting
Journal for ImmunoTherapy of Cancer
2021/10/11
Jiri Eitler
H-Index: 4
Nicole Miller
H-Index: 1
PROMOTER CHOICE: THE IDEAL PROMOTER TO DRIVE CHIMERIC ANTIGEN RECEPTOR (CAR) EXPRESSION IN NK CELLS
Hematology, Transfusion and Cell Therapy
2021/10/1
Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting
Journal for immunotherapy of cancer
2021
Jiri Eitler
H-Index: 4
Nicole Miller
H-Index: 1
Live cell imaging of lytic granule motility in anti-erbb2 car nk cells and fcr nk cells plus herceptin towards erbb2+ breast cancer cells
Cytotherapy
2020/5/1
Competing interests
J Am Coll Surg
2015
Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment
Hematology, Transfusion and Cell Therapy
2020
